000 01328 a2200325 4500
005 20250518083133.0
264 0 _c20200807
008 202008s 0 0 eng d
022 _a1879-2596
024 7 _a10.1016/j.bbamcr.2020.118664
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLauretti, Elisabetta
245 0 0 _aGlycogen synthase kinase-3 signaling in Alzheimer's disease.
_h[electronic resource]
260 _bBiochimica et biophysica acta. Molecular cell research
_c05 2020
300 _a118664 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAlzheimer Disease
_xdrug therapy
650 0 4 _aGene Expression Regulation
650 0 4 _aGlycogen Synthase Kinase 3 beta
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aPhosphorylation
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _atau Proteins
_xmetabolism
700 1 _aDincer, Ozlem
700 1 _aPraticò, Domenico
773 0 _tBiochimica et biophysica acta. Molecular cell research
_gvol. 1867
_gno. 5
_gp. 118664
856 4 0 _uhttps://doi.org/10.1016/j.bbamcr.2020.118664
_zAvailable from publisher's website
999 _c30584497
_d30584497